FR1130M - Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales. - Google Patents

Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.

Info

Publication number
FR1130M
FR1130M FR860979A FR860979A FR1130M FR 1130 M FR1130 M FR 1130M FR 860979 A FR860979 A FR 860979A FR 860979 A FR860979 A FR 860979A FR 1130 M FR1130 M FR 1130M
Authority
FR
France
Prior art keywords
pyrrolidly
phenothiazine
dimethyl
methyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR860979A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag Chemie Ltd
Original Assignee
Cilag Chemie Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR851797A external-priority patent/FR1302389A/fr
Application filed by Cilag Chemie Ltd filed Critical Cilag Chemie Ltd
Priority to FR860979A priority Critical patent/FR1130M/fr
Application granted granted Critical
Publication of FR1130M publication Critical patent/FR1130M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FR860979A 1960-02-05 1961-05-05 Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales. Active FR1130M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR860979A FR1130M (fr) 1960-02-05 1961-05-05 Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH131560A CH375717A (de) 1960-02-05 1960-02-05 Verfahren zur Herstellung von neuen Phenothiazinderivaten
CH975060A CH381691A (de) 1960-02-05 1960-08-29 Verfahren zur Herstellung von neuen Phenothiazinderivaten
FR851797A FR1302389A (fr) 1960-02-05 1961-02-06 Fabrication de nouveaux dérivés de la phénothiazine et de leurs sels
FR860979A FR1130M (fr) 1960-02-05 1961-05-05 Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.

Publications (1)

Publication Number Publication Date
FR1130M true FR1130M (fr) 1962-02-19

Family

ID=4207559

Family Applications (1)

Application Number Title Priority Date Filing Date
FR860979A Active FR1130M (fr) 1960-02-05 1961-05-05 Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.

Country Status (8)

Country Link
US (1) US3140284A (fr)
BE (1) BE599916A (fr)
CH (2) CH375717A (fr)
DE (1) DE1147946B (fr)
ES (1) ES264624A1 (fr)
FR (1) FR1130M (fr)
GB (1) GB917817A (fr)
NL (1) NL260841A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987042A (en) * 1969-03-03 1976-10-19 Claude Gueremy Phenothiazine derivative
US4018922A (en) * 1971-05-14 1977-04-19 Roussel-Uclaf 10-(Piperidin o-alkyl)-phenothiazines
US3891636A (en) * 1972-05-11 1975-06-24 Roussel Uclaf 10-(Piperidino-alkyl) -phenothiazines
SI1650186T1 (sl) * 2004-10-22 2008-12-31 Bioprojet Soc Civ Novi derivati dikarboksilne kisline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826588A (en) * 1958-03-11 J-di-substituted pyrrolidine compounds
US2931810A (en) * 1960-04-05 Phenothiazine derivatives
DE1049382B (de) * 1955-10-10 1959-01-29 CILAG Aktiengesellschaft, Schaffhausen (Schweiz) Verfahren zur Herstellung von 10-(Pyrrolidyl-3-methyl)-phenthiazinen, ihren Salzen und quaternären Ammoniumsalzen
NL244514A (fr) * 1958-10-21
US2975193A (en) * 1959-06-18 1961-03-14 Parke Davis & Co Organic amine compounds and method of obtaining the same

Also Published As

Publication number Publication date
DE1147946B (de) 1963-05-02
GB917817A (en) 1963-02-06
US3140284A (en) 1964-07-07
BE599916A (fr)
CH375717A (de) 1964-03-15
ES264624A1 (es) 1961-04-01
NL260841A (fr)
CH381691A (de) 1964-09-15

Similar Documents

Publication Publication Date Title
FR2427M (fr) Médicament bactériothérapique, en particulier pour le traitement d'affections gastro-intestinales.
FR1038M (fr) Médicament a base d'aspirine.
FR2984M (fr) Médicament pour le traitement de troubles cardiovasculaires a base de dl-4-(acéthyl-aminométhyl)-1-[2-(1,4-benzodioxanyl)-méthyl]-4-phénylpipéridine.
OA05587A (fr) Pulvérisateur portatif, notamment pour le traitement des cultures.
FR1130M (fr) Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.
FR2243M (fr) Médicaments nouveaux, a base de dérivés naphtaléniques optiquement actifs, pour le traitement de maladies du coeur.
FR1009M (fr) Médicament pour le traitement de l'angine de poitrine.
FR2944M (fr) Médicament pour le traitement de la toux a base de 2-amino-6-méthylheptane.
FR126M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR2753M (fr) Médicament a base de 2-(benzenesulfonyl)-amino-5-phénylpyrimidine pour réduire le taux de la glycémie.
FR1443M (fr) Préparation dermatologique.
FR1242M (fr) Médicament, utilisable notamment pour le traitement des affections fongiques, a base de dérivés de la griséofulvine.
FR1489M (fr) Diphénlysulfones substituées en 4,4' et leurs préparations pharmaceutiques pour le traitement des maladies virales.
FR1738M (fr) Médicament a base de bis- (β-carbhydrazido-éthyl)-sulfone pour le traitement de la bilharziose.
FR1967M (fr) Médicaments a base de dérivés du 1,3,4,-thiadiazole pour le traitement de l'épilepsie.
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l'hyperlipémie chronique ou post-prandiale.
FR2002M (fr) Comprimé a base de complexe actif de pantothénate de calcium pour le traitement des atonies intestinales et des avitaminoses.
FR3153M (fr) Médicament pour le traitement des affections des coronaires, a base d'isopropylidene-2',3' adénosine.
FR3064M (fr) Médicaments a base de composés aryl-thio-aliphatiques pour le traitement de l'athérosclérose.
FR32M (fr) Nouveau médicament déserpidique 6b-éthyle pour le traitement de l'hypertension artérielle.
FR1143M (fr) Médicament a base de dérivé pyimidique, notamment pour le traitement de l'hypercholestérolémie et de l'hyper-uricémie.
FR2786M (fr) Médicament pour le traitement des maladies cardiaques.
BE605228A (fr) Dispositif pour le traitement d'agglomérés de houille.
FR1206122A (fr) Pansement pour le bout du doigt
BE598665A (fr) Préparations pharmaceutiques pour le traitement de la leucémie.